What is Option Care Health Inc (OPCH)?
Option Care Health Inc is a provider of home and alternate site infusion services in the United States. The company specializes in delivering intravenous therapies and other complex medications to patients in their homes or other care settings outside of traditional hospitals. Its services encompass a range of treatments including antibiotics, nutrition, pain management, and other specialty therapies. The company operates through a network of locations and partners with healthcare providers, insurers, and pharmaceutical manufacturers to facilitate patient access to infusion care. Its business model focuses on improving patient outcomes by enabling treatment in less intensive environments, which can also contribute to reducing overall healthcare costs. The company is part of the broader healthcare sector, specifically within the home healthcare and specialty infusion services industry. It plays a role in supporting patients with chronic or acute conditions requiring ongoing infusion therapy, emphasizing clinical expertise, patient safety, and adherence to regulatory standards.
Option Care Health Inc Stock Price Today: Live Overview
The price today is shaped by active intraday trading, with Option Care Health Inc currently at $28.54. It has fluctuated between $28.27 and $28.73, reflecting a daily change of +0.2116%.
FAQ: Option Care Health Inc (OPCH)
What is the current price of OPCH stock?
Option Care Health Inc's current price is $28.54.
Does OPCH pay dividends?
Option Care Health Inc pays dividends.
Does OPCH have a formal corporate presence or regional headquarters in the UAE?
The company does not have an official regional office, subsidiary, or registered presence in the UAE and operates via partners or distributors.
What is OPCH best known for?
Option Care Health Inc is most famous for providing home infusion services and specialty pharmaceutical treatments.
What assets are typically shown together with OPCH?
Commonly shown alongside OPCH: Middlesex Water Co, Wix.com Ltd, Pernod Ricard
Latest shares articles



